Chromatin modifier enzymes, the histone code and cancer.

Area of Science:

• Molecular Biology
• Cancer Biology
• Epigenetics

Background:

• Cell proliferation relies on precise gene expression patterns orchestrated by transcription factors.
• Aberrant transcription regulation is increasingly linked to human cancer development.
• Transcription regulatory proteins are frequently implicated in oncogenic chromosomal rearrangements and overexpression in malignancies.

Purpose of the Study:

• To review transcription activators and repressors that catalyze histone post-translational modifications.
• To elucidate how these enzymatic activities contribute to altered cell proliferation and cancer.

Main Methods:

• Literature review focusing on transcription regulators and chromatin modifiers.
• Analysis of enzymatic activities involved in histone post-translational modifications (acetylation, methylation, phosphorylation, ubiquitination, SUMOylation).
• Examination of the link between these modifications and cell proliferation control.

Main Results:

• Transcription regulators, often possessing enzymatic activity, modify chromatin structure.
• Chromatin modifiers provide an additional layer of transcription regulation.
• Specific families of transcription activators and repressors catalyze key histone modifications.

Conclusions:

• Enzymatic activities of transcription regulators on histones are critical for normal cell proliferation.
• Dysregulation of these chromatin-modifying enzymes can disrupt cell cycle control, promoting cancer.
• Understanding these mechanisms offers insights into cancer development and potential therapeutic targets.